AstraZeneca has adopted Horizon Discovery’s Edit-R crRNA libraries as part of its initiative to establish a functional genomics discovery platform. AstraZeneca also joins the Genomics Discovery Initiative (GDI), a collaborative functional genomics screening community facilitated by Horizon. AstraZeneca has been evaluating Horizon’s Edit-R human whole genome crRNA library for gene knockout since late 2017, and will soon add the company’s platform of arrayed synthetic crRNA li...